Notice2021-26717
Notice of Commission Determination Not To Review an Initial Determination Granting a Motion for Return of a Bond; Certain Microfluidic Systems and Components Thereof and Products Containing Same
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
December 10, 2021
Issuing agencies
International Trade Commission
Abstract
Notice is hereby given that the U.S. International Trade Commission ("Commission") has determined not to review an initial determination ("ID") (Order No. 46) of the presiding administrative law judge ("ALJ"), granting respondent Bio-Rad Laboratories, Inc.'s motion for return of the bond it posted during the period of Presidential Review.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 235 (Friday, December 10, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 235 (Friday, December 10, 2021)]
[Notices]
[Page 70527]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-26717]
[[Page 70527]]
=======================================================================
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation No. 337-TA-1100]
Notice of Commission Determination Not To Review an Initial
Determination Granting a Motion for Return of a Bond; Certain
Microfluidic Systems and Components Thereof and Products Containing
Same
AGENCY: U.S. International Trade Commission.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that the U.S. International Trade
Commission (``Commission'') has determined not to review an initial
determination (``ID'') (Order No. 46) of the presiding administrative
law judge (``ALJ''), granting respondent Bio-Rad Laboratories, Inc.'s
motion for return of the bond it posted during the period of
Presidential Review.
FOR FURTHER INFORMATION CONTACT: Benjamin S. Richards, Esq., Office of
the General Counsel, U.S. International Trade Commission, 500 E Street
SW, Washington, DC 20436, telephone (202) 708-5453. Copies of non-
confidential documents filed in connection with this investigation may
be viewed on the Commission's electronic docket (EDIS) at <a href="https://edis.usitc.gov">https://edis.usitc.gov</a>. For help accessing EDIS, please email
<a href="/cdn-cgi/l/email-protection#3e7b7a776d0d765b524e7e4b4d574a5d10595148"><span class="__cf_email__" data-cfemail="b5f0f1fce686fdd0d9c5f5c0c6dcc1d69bd2dac3">[email protected]</span></a>. General information concerning the Commission may
also be obtained by accessing its internet server at <a href="https://www.usitc.gov">https://www.usitc.gov</a>. Hearing-impaired persons are advised that information on
this matter can be obtained by contacting the Commission's TDD terminal
on (202) 205-1810.
SUPPLEMENTARY INFORMATION: On February 21, 2018, the Commission
instituted this investigation based on a complaint filed by 10X
Genomics, Inc. of Pleasanton, CA (``10X''). 83 FR 7491 (Feb. 21, 2018).
The complaint alleged violations of section 337 of the Tariff Act of
1930, as amended, 19 U.S.C. 1337, in the importation into the United
States, the sale for importation, or the sale within the United States
after importation of certain microfluidic systems and components
thereof and products containing same by reason of infringement of one
or more claims of U.S. Patent Nos. 9,644,204; 9,689,024; 9,695,468; and
9,856,530. Id. The Commission's notice of investigation named as the
sole respondent Bio-Rad Laboratories, Inc. of Hercules, CA (``Bio-
Rad''). Id. The Office of Unfair Import Investigations participated in
this investigation. Id.
On February 12, 2020, the Commission issued its opinion and final
determination in this investigation, which found Bio-Rad in violation
of section 337. The Commission also issued remedial orders on that date
and set a bond of twenty-five percent (25%) of the entered value of the
articles subject to the remedial orders during the period of
Presidential review. Pursuant to that bond provision, Bio-Rad posted
bond in the amount of $6,554.68.
On July 26, 2021, Bio-Rad agreed to a settlement resolving the
dispute in this investigation. Pursuant to a joint request by Bio-Rad
and 10X, the Commission reviewed the settlement agreement and issued an
order rescinding the remedial orders in this investigation on August
25, 2021. See 86 FR 48441-42 (Aug. 30, 2021).
On July 28, 2021, shortly after entering the settlement agreement
with 10X, Bio-Rad moved without opposition for the return of its bond.
On October 21, 2021, the presiding ALJ issued the subject ID, which
granted Bio-Rad's motion. No petitions for review of that ID have been
received.
The Commission has determined not to review the subject ID. The
bond at issue is ordered to be returned to Bio-Rad.
The Commission vote for this determination took place on December
6, 2021.
The authority for the Commission's determination is contained in
section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and
in Part 210 of the Commission's Rules of Practice and Procedure (19 CFR
part 210).
By order of the Commission.
Issued: December 6, 2021.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2021-26717 Filed 12-9-21; 8:45 am]
BILLING CODE 7020-02-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on December 10, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.